Pharma Mar (XMAD:PHM) Net Interest Margin (Bank Only) %


XMAD:PHM Pharma Mar SA XMAD:PHM
84 GF Score
Price €73.10
GF Value €83.14
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Pharma Mar Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XMAD:PHM
84GF Score
Pharma Mar SA XMAD:PHM
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pharma Mar (XMAD:PHM) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of €73.10 is trading 12.1% below its estimated GF Value™ of €83.14. GuruFocus considers Pharma Mar to be Modestly Undervalued.

Key valuation signals for XMAD:PHM:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €83.14 vs. price of €73.10 (12.1% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the XMAD:PHM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
84GF Score

Get the complete analysis for XMAD:PHM

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€73.10
Price
€83.14
GF Value